MU Investments Co. Ltd. Has $109,000 Position in CVS Health Corporation (CVS)
MU Investments Co. Ltd. increased its position in CVS Health Corporation (NYSE:CVS) by 62.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,150 shares of the pharmacy operator’s stock after buying an additional 440 shares during the period. MU Investments Co. Ltd.’s holdings in CVS Health Corporation were worth $109,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. River Wealth Advisors LLC raised its position in shares of CVS Health Corporation by 5.4% in the first quarter. River Wealth Advisors LLC now owns 22,782 shares of the pharmacy operator’s stock worth $2,363,000 after buying an additional 1,160 shares during the last quarter. Telemus Capital LLC increased its stake in CVS Health Corporation by 64.2% in the first quarter. Telemus Capital LLC now owns 25,438 shares of the pharmacy operator’s stock worth $2,639,000 after buying an additional 9,942 shares during the period. Arvest Bank Trust Division increased its stake in CVS Health Corporation by 2.5% in the first quarter. Arvest Bank Trust Division now owns 197,671 shares of the pharmacy operator’s stock worth $20,505,000 after buying an additional 4,880 shares during the period. Sanders Morris Harris Inc. acquired a new stake in CVS Health Corporation during the first quarter worth $1,390,000. Finally, Sii Investments Inc. WI increased its stake in CVS Health Corporation by 59.8% in the first quarter. Sii Investments Inc. WI now owns 18,071 shares of the pharmacy operator’s stock worth $1,862,000 after buying an additional 6,762 shares during the period. Institutional investors own 80.95% of the company’s stock.
Shares of CVS Health Corporation (NYSE:CVS) traded up 0.50% during trading on Monday, hitting $86.83. 5,342,374 shares of the stock traded hands. The stock has a market cap of $92.58 billion, a price-to-earnings ratio of 19.97 and a beta of 0.83. CVS Health Corporation has a 1-year low of $85.89 and a 1-year high of $106.67. The stock has a 50 day moving average price of $91.41 and a 200-day moving average price of $96.91.
CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. The company earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. CVS Health Corporation’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.19 EPS. Equities analysts forecast that CVS Health Corporation will post $5.86 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th will be paid a $0.425 dividend. The ex-dividend date is Thursday, October 20th. This represents a $1.70 annualized dividend and a dividend yield of 1.96%. CVS Health Corporation’s dividend payout ratio is currently 39.08%.
A number of equities research analysts recently weighed in on CVS shares. Mizuho reissued a “buy” rating and set a $111.00 price target on shares of CVS Health Corporation in a research note on Friday, September 30th. Morgan Stanley reissued a “hold” rating and set a $104.00 price target on shares of CVS Health Corporation in a research note on Monday, September 12th. Leerink Swann reissued an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of CVS Health Corporation in a research note on Sunday, October 2nd. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “hold” rating and set a $87.73 price target for the company. in a research note on Thursday. Finally, Credit Suisse Group AG reissued a “buy” rating and set a $115.00 price target on shares of CVS Health Corporation in a research note on Tuesday, September 20th. Five research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $112.40.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.